Company intelligence / Profile preview

Covalent Pharma

Hyderabad, Telangana, Indiadnb.com ↗

Ownership: Private
Development stage: Commercial

Overview

Covalent Laboratories manufactures and supplies active pharmaceutical ingredients (APIs), primarily cephalosporins, for both Indian and international markets. The company holds multiple quality certifications including ISO 9001/14001, WHO-GMP, USFDA, and KFDA. It has expanded into sterile APIs since 2014. No clinical trial results are reported as it is an API manufacturer rather than a drug developer.

Therapeutic areas: Infectious Diseases
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Covalent Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Covalent Pharma.

Explore the full profile